ADVANTAGE: Who was actually in charge of R&D? And other question...

Courtesy Health Care Renewal  Wed, 08/20/2008 - 11:18

Roy Poses addresses many of the controversial issues raised by the Annals of Internal Medicine article "The ADVANTAGE seeding trial: a review of internal documents" in "Bad Seed: the ADVANTAGE Trial of Vioxx ."

I wish to raise a few additional questions:

The Wall Street Journal and others pointed out that Edward Scolnick, MD, President of Merck Research Labs and largely seen as the #2 official in the company, worried that the ADVANTAGE study...

Tags:

 

More related items

FDA approves Vidaza label expansion
(Weber Shandwick Worldwide) The Aplastic Anemia & MDS International Foundation is pleased to inform patients that the US Food and Drug Administration...

Bad Seed: the ADVANTAGE Trial of Vioxx
An article in the Annals of Internal Medicine by Hill et al(1), and the accompanying editorial by Sox and Rennie(2) have created quite a stir in the...

FDA Draft Report: No Risk From BPA In Food Containers
A controversial chemical commonly found in can linings, baby bottles and other household products does not pose a health hazard when used in food...

FDA Warns Consumers Not to Eat Certain Mussel Products from...
The U.S. Food and Drug Administration (FDA) is warning consumers against eating certain frozen cooked mussel products made by Bantry Bay Seafoods,...

A Healthy Horse the Natural Way: A Horse Owner's Guide to Using...

What Your Doctor May Not Tell You About Fibromyalgia: The...
In this book Dr. R. Paul St. Amand offers the first effective protocol to help reverse the autoimmune disorder, Fibromyalgia, in children. The...

Good Calories, Bad Calories
In this groundbreaking book, the result of seven years of research in every science connected with the impact of nutrition on health, award-winning...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com